Compare HROW & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | DGII |
|---|---|---|
| Founded | 1998 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | N/A |
| Metric | HROW | DGII |
|---|---|---|
| Price | $41.34 | $41.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $68.86 | $46.80 |
| AVG Volume (30 Days) | ★ 716.4K | 248.3K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.05 |
| EPS | N/A | ★ 1.08 |
| Revenue | $250,042,000.00 | ★ $430,221,000.00 |
| Revenue This Year | $43.92 | $8.57 |
| Revenue Next Year | $41.22 | $3.72 |
| P/E Ratio | ★ N/A | $38.81 |
| Revenue Growth | ★ 47.83 | 1.46 |
| 52 Week Low | $20.85 | $22.39 |
| 52 Week High | $50.72 | $44.79 |
| Indicator | HROW | DGII |
|---|---|---|
| Relative Strength Index (RSI) | 58.85 | 65.73 |
| Support Level | $36.95 | $36.89 |
| Resistance Level | $41.24 | $43.58 |
| Average True Range (ATR) | 2.64 | 2.23 |
| MACD | 0.52 | 0.52 |
| Stochastic Oscillator | 89.48 | 69.29 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.